Xanthines Down-Regulate the Drug Transporter ABCG2 and Reverse Multidrug Resistance
Authors:
- Jia ShiJSJia Shi
- Kirk PabonKPKirk Pabon
- Kathleen W. ScottoKSKathleen W. Scotto
- 1 March 2012
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 81 (3) , 328-337
Abstract
ABCG2 is an ATP-binding-cassette (ABC) transporter that confers multidrug resistance (MDR) to tumor cells by extruding a broad variety of chemotherapeutic agents, ultimately leading to failure of cancer therapy. Thus, the down-regulation of ABCG2 expression and/or function has been proposed as part of a regimen to improve cancer therapeutic efficacy. In this study, we found that a group of xanthines including caffeine, theophylline, and dyphylline can dramatically decrease ABCG2 protein in cells that have either moderate (BeWo, a placental choriocarcinoma cell line) or high (MCF-7/MX100, a breast cancer drug-resistant cell subline) levels of ABCG2 expression. This down-regulation is time-dependent, dose-dependent, and reversible. Using lysosomal inhibitors, we found that xanthines decreased ABCG2 by inducing its rapid internalization and lysosome-mediated degradation. As a consequence, caffeine treatment significantly increased the retention of an established ABCG2 substrate in MCF-7/MX100 cells but not in parental MCF-7 cells and sensitized the MDR cells to the chemotherapeutic agent mitoxantrone (MX); combination treatment with MX and caffeine decreased the IC50 of MX ∼10-fold and induced a greater degree of apoptotic cell death than MX treatment alone. Taken together, our results describe a novel function for this large class of therapeutically relevant compounds and suggest that a subset of xanthines could be developed as combination therapy to improve the efficacy of anticancer drugs that are ABCG2 substrates.Keywords
This publication has 46 references indexed in Scilit:
- Dynamic vs Static ABCG2 Inhibitors to Sensitize Drug Resistant Cancer CellsPLOS ONE, 2010
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like CellsCell Stem Cell, 2009
- ABCG2: A perspectiveAdvanced Drug Delivery Reviews, 2009
- Effect of Caffeine on the ATR/Chk1 Pathway in the Epidermis of UVB-Irradiated MiceCancer Research, 2008
- Caffeine Regulates Alternative Splicing in a Subset of Cancer-Associated Genes: a Role for SC35Molecular and Cellular Biology, 2008
- Caffeine analogs: biomedical impactCellular and Molecular Life Sciences, 2007
- Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B2) into MilkMolecular and Cellular Biology, 2007
- ABCG2 expression, function, and promoter methylation in human multiple myelomaBlood, 2006
- Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome predictionBlood, 2006
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005